Hydrops Fetalis

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Hydrops Fetalis trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 3 trials

RecruitingNot Applicable

NCT03775954

Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise

Each year world-wide, 2.5 million fetuses die unexpectedly in the last half of pregnancy, 25,000 in the United States, making fetal demise ten-times more common…

United States30 participantsStarted 2018-07-01

Treatment: Fetal Magnetocardiogram and Neonatal Electrocardiogram, Substudy only: Maternal/Infant Pharmacogenomic assessment postnatally

RecruitingNot Applicable

NCT03911531

Whole Exome Sequencing and Whole Genome Sequencing for Nonimmune Fetal/Neonatal Hydrops

Brief Summary: Nonimmune hydrops fetalis (NIHF) is a potentially fatal condition characterized by abnormal fluid accumulation in two or more fetal compartments.…

United States55 participantsStarted 2019-01-15

Treatment: Whole Exome Sequencing, Whole Genome Sequencing

RecruitingNot Applicable

NCT05797272

In-utero Hematopoietic Stem Cell Transplantation for the Treatment of Fetuses With Bart's Hydrops Fetalis Syndrome

This is a prospective observational pilot study on pregnant women who are diagnosed to have Bart's hydrops fetalis syndrome (BHFS) affected fetuses and opt for…

Hong Kong10 participantsStarted 2021-10-01

Treatment: in-utero HSCT

All recent trials (10 shown)

Active — Not RecruitingNot Applicable

NCT03412760

Hydrops: Diagnosing & Redefining Outcomes With Precision Study

This is a national, prospective study designed to investigate the genetic etiologies of non-immune hydrops fetalis (NIHF) and other birth defects. At least half…

United States500 participantsStarted 2018-10-11

Treatment: Exome sequencing

By InvitationNot Applicable

NCT05528796

Uncovering the Etiologies of Non-immune Hydrops Fetalis

Non-immune hydrops fetalis (NIHF) is diagnosed on prenatal ultrasound when abnormal fluid collections are seen in the fetus. NIHF carries significant risks of s…

United States500 participantsStarted 2022-03-01

Treatment: Whole genome sequencing

Hydrops Fetalis

Trial phase breakdown

Trial status

Actively recruiting — 3 trials

Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise

Whole Exome Sequencing and Whole Genome Sequencing for Nonimmune Fetal/Neonatal Hydrops

In-utero Hematopoietic Stem Cell Transplantation for the Treatment of Fetuses With Bart's Hydrops Fetalis Syndrome

All recent trials (10 shown)

Hydrops: Diagnosing & Redefining Outcomes With Precision Study

Uncovering the Etiologies of Non-immune Hydrops Fetalis

Trial phase breakdown

Trial status

Actively recruiting — 3 trials

Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise

Whole Exome Sequencing and Whole Genome Sequencing for Nonimmune Fetal/Neonatal Hydrops

In-utero Hematopoietic Stem Cell Transplantation for the Treatment of Fetuses With Bart's Hydrops Fetalis Syndrome

All recent trials (10 shown)

Hydrops: Diagnosing & Redefining Outcomes With Precision Study

Uncovering the Etiologies of Non-immune Hydrops Fetalis

Prospective Observational Cohort Study of Fetal Atrial Flutter & Supraventricular Tachycardia

In Utero Hematopoietic Stem Cell Transplantation for Alpha-thalassemia Major (ATM)

Multicentric Prospective Study to Screen Inborn Errors of Metabolism in Non-immune Hydrops (NIH) Fetalis by Massively Pa…

Precision Medical Research of Non-immune Fetal Hydrops (NIFH)-From Prenatal Diagnosis to Intrauterine Treatment

Amniotic Fluid Tandem Mass Spectrometry for Pregnancies Complicated by NIH and Severe Symmetrical IUGR